Investment
Features
FeesSafety
Academy
More
Pluang+

Compare Centene Corp (CNC) vs Nvidia Corp (NVDA) Price & Performance

Centene CorpTrade
Nvidia CorpTrade

Price performance (Past 24H)

Key statistics

Centene Corp vs Nvidia Corp — how do they compare? Centene Corp trades at $66.88 (market cap $33.93B), while Nvidia Corp trades at $208.22 (market cap $5.13T). The key difference: Nvidia Corp is far larger — about 151.2× Centene Corp's market cap, and Nvidia Corp pays a 0.47% dividend while Centene Corp pays none. Which is the better fit depends on your goals.

CNCNVDA
Market Cap
$33.93B$5.13T
Sector
HealthTechnology
52-Week High
$68.72$235.75
52-Week Low
$25.21$165.17
Enterprise Value
$26.56B$5.06T
Dividend Yield
0.47%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

Centene Corp

Centene Corporation (CNC) trades at $68.29, up 1.4% with strong technical momentum and bullish moving average signals. The stock shows impressive 66% YTD gains, supported by recent contract renewals and margin recovery initiatives. Despite negative 2025 net income of -$6.67B, valuation metrics remain attractive with P/E of 8.06 and P/S of 0.17. Analyst consensus is strongly bullish with 61% buy ratings and $66.07 price target.

Centene presents a compelling value opportunity with low valuation multiples and strong operational cash flow of $5.09B. Key risks include ongoing margin pressure and Medicaid contract dependency. The company's AI-driven cost controls and recent Illinois Medicaid renewal provide catalysts for earnings recovery, though healthcare regulatory changes remain a concern for long-term stability.

Nvidia Corp

NVIDIA (NVDA) trades at $208.23, up 2.31% on the day, with a bullish technical signal from moving averages. The stock shows exceptional fundamental strength with revenue soaring to $130.5B in 2025 and net income margins reaching 62.97%. Recent quarterly earnings have consistently beaten expectations, with Q1 2026 EPS of $1.87 surpassing the $1.76 estimate. The company maintains robust profitability metrics including 74.15% gross margins and 114.29% ROE, though valuation ratios remain elevated with P/E at 32.43 and P/S at 20.44.

The outlook remains positive with strong analyst consensus (75.32% buy ratings) and a $325.86 price target suggesting significant upside. Key opportunities include continued AI chip dominance and expanding market opportunities, while risks include increased competition, potential peak AI infrastructure spending, and elevated valuation multiples that could limit near-term growth. The stock's proximity to its 52-week high warrants monitoring of momentum sustainability.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About Centene Corp

Centene is a managed-care organization focused on government-sponsored healthcare plans, including Medicaid, Medicare, and the individual exchanges. Centene served 22 million medical members as of September 2021, mostly in Medicaid (68% of membership), the individual exchanges (10%), Medicare Advantage (6%), and the balance in Tricare (West region), correctional facility, and international plans. The company also serves 4 million users through the Medicare Part D pharmaceutical program.

Read more on CNC

About Nvidia Corp

NVIDIA Corporation designs, develops, and markets three dimensional (3D) graphics processors and related software. The Company offers products that provides interactive 3D graphics to the mainstream personal computer market.

Read more on NVDA